Follow the Fujian Haixi Pharmaceuticals Co., Ltd. - H Shares stock price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares trade on the HK market, under the supervision of HKEX. Market capitalisation: €6bn. The latest transaction was filed on 2 July 2026 (Purchase). Among the most active insiders: Feng Yan. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
福建海西药业有限公司是一家从事药物研发和生产的中国制药公司。该公司在H股市场上市。